| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
5,524,000 |
| Market
Cap: |
570.02(M) |
| Last
Volume: |
19,542 |
Avg
Vol: |
40,496 |
| 52
Week Range: |
$84.55 - $168.51 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
| Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
| Total People Sold |
0 |
1 |
3 |
8 |
| Total Sell Transactions |
0 |
1 |
5 |
25 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guillemin Evan |
Director |
– • – |
2021-07-16 |
4 |
AS |
$282.18 |
$203,170 |
D/D |
(720) |
29,450 |
|
10% |
|
| Sakys John V |
CFO |
• – – |
2021-07-12 |
4 |
AS |
$278.77 |
$278,770 |
D/D |
(1,000) |
7,514 |
|
9% |
|
| Sakys John V |
CFO |
• – – |
2021-07-12 |
4 |
OE |
$89.70 |
$89,700 |
D/D |
1,000 |
8,514 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-07-01 |
4 |
S |
$267.04 |
$267,040 |
D/D |
(1,000) |
7,514 |
|
-20% |
|
| Sakys John V |
CFO |
• – – |
2021-07-01 |
4 |
OE |
$89.70 |
$89,700 |
D/D |
1,000 |
8,514 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-07-01 |
4 |
AS |
$267.44 |
$334,300 |
D/D |
(1,250) |
24,299 |
|
20% |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2021-06-17 |
4 |
S |
$256.56 |
$102,624 |
D/D |
(400) |
793 |
|
-16% |
|
| Dinoia Gregory |
SVP Commericial |
• – – |
2021-06-16 |
4 |
S |
$255.67 |
$309,616 |
D/D |
(1,211) |
2,973 |
|
-16% |
|
| Schmieder John Bradley |
Director |
– • – |
2021-06-16 |
4 |
AS |
$262.27 |
$132,446 |
D/D |
(505) |
71,507 |
|
16% |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2021-06-16 |
4 |
S |
$255.67 |
$343,430 |
D/D |
(1,336) |
1,193 |
|
-16% |
|
| Owens Gary M |
President and CEO |
• • – |
2021-06-16 |
4 |
S |
$255.67 |
$1,673,360 |
D/D |
(6,545) |
18,396 |
|
-16% |
|
| Sakys John V |
CFO |
• – – |
2021-06-16 |
4 |
S |
$255.67 |
$541,765 |
D/D |
(2,119) |
7,514 |
|
-16% |
|
| Dinoia Gregory |
SVP Commericial |
• – – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,800 |
4,184 |
|
- |
|
| Archbold Brian David |
SVP Continuous Improvement |
• – – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,960 |
2,529 |
|
- |
|
| Owens Gary M |
President and CEO |
• • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,448 |
24,941 |
|
- |
|
| Sakys John V |
CFO |
• – – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,676 |
9,633 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-06-10 |
4 |
OE |
$70.56 |
$76,660 |
D/D |
1,001 |
25,209 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-06-08 |
4 |
S |
$258.19 |
$1,340,522 |
D/D |
(5,192) |
24,208 |
|
-20% |
|
| Sullivan John James |
Director |
– • – |
2021-06-08 |
4 |
OE |
$89.70 |
$465,722 |
D/D |
5,192 |
29,400 |
|
- |
|
| Owens Gary M |
President and CEO |
• – – |
2021-06-07 |
4 |
S |
$264.00 |
$356,400 |
D/D |
(1,350) |
8,513 |
|
-19% |
|
| Kelly David M |
Director |
– • – |
2021-06-04 |
4 |
S |
$260.28 |
$221,498 |
D/D |
(851) |
2,600 |
|
-18% |
|
| Kelly David M |
Director |
– • – |
2021-06-04 |
4 |
OE |
$70.56 |
$85,668 |
D/D |
851 |
3,451 |
|
- |
|
| Dinoia Gregory |
SVP Commercial |
• – – |
2021-06-04 |
4 |
S |
$260.27 |
$140,546 |
D/D |
(540) |
840 |
|
-18% |
|
| Dinoia Gregory |
SVP Commercial |
• – – |
2021-06-04 |
4 |
OE |
$142.40 |
$76,896 |
D/D |
540 |
1,380 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2021-06-01 |
4 |
AS |
$251.46 |
$556,984 |
D/D |
(2,215) |
24,208 |
|
22% |
|
176 Records found
|
|
Page 4 of 8 |
|
|
1.39 (1.37%) 
